CD27 and laryngotracheoesophageal cleft: LC patients with active disease had significantly decreased levels of TIM-3 (Figure 4G), an inhibitory biomarker expressed on T helper 1 cells and the co-stimulatory molecule CD27 in comparison to healthy controls (Figure 4K).